On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Dr. Ahn co-chaired the 2017 Clinical Diabetes Technology Meeting and authored a chapter in the ADA-published Diabetes Technology Science ... other partners to ensure our products meet the highest ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Balancing your blood sugar and reducing the risk of health issues can be a challenge for people with diabetes when a cold or ...

Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...

A University of Florida study finds that people with diabetes who participate in telehealth doctor visits report the same ...

Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

That three-pronged attack helped patients lose an average of about 24% of their body weight at 48 weeks in a phase 2 trial presented at the American Diabetes Association (ADA) congress.

Researchers reveal that spermidine-mediated acetylhypusination of RIPK1 suppresses necroptosis and insulin resistance, ...

Ascensia has created a virtual wellness zone to answer questions aligning to the IDF's 2024 theme of 'Diabetes and Well-being' Insights from our expert panel of endocrinologists, psychologists and ...

Holistic medicine emphasizes the importance of taking proactive steps to improve one’s lifestyle, reduce stress, and eat ...

Diabetes mellitus is one of the most common ... The aim of this review is to review international guidelines regarding the management of GDM and to propose possible new therapies.